Vinod Kumar, Prashant Kumar, Saurabh Sharma
Vinod Kumar1*, Prashant Kumar2, Saurabh Sharma1
1Research Scholar, School of Research, Pharmaceutical Sciences, CT University, Ferozepur Road, Sidhwan Khurd, Punjab, India - 142024.
1School of Pharmaceutical Sciences, CT University, Ferozepur Road, Sidhwan Khurd, Punjab, India - 142024.
2College of Pharmacy, Teerthanker Mahaveer University, Moradabad, Uttar Pradesh India - 244001.
Volume - 16,
Issue - 3,
Year - 2023
Psoriasis is the most common chronic autoimmune disease. The pathophysiology, genetics, comorbidities, and biologic therapies of plaque psoriasis have seen the most rapid advances. Only a tiny percentage of the supplied dose reaches the target site in most situations (traditional dosage forms), while the balance is distributed throughout the body according to its physicochemical and biochemical properties. The current worker used nanotechnology to carry out study on the formulation and evaluation of nanoparticulate Berberine HCl loaded Chitosan coated sodium alginate nanoparticles. The Berberine HCl Nanoparticles were optimised using the Box-Behnken design. Particle size (68.82-275.78nm), zeta potential ((10.90)– (47.1 mv), percentage yield (80.75 percent - 96.21percent), percentage drug entrapment (50.95 -77.28percent), and percentage release in pH 7.4 phosphate buffer (60.848 - 95.869percent) were all found to be positive with Berberine HCl nanoparticles. Nanoparticles were found to be spherical in shape with rough surfaces, according to surface morphology (SEM). In a pH 7.4 phosphate buffer, an in-vitro drug release investigation on an optimised batch of Berberine HCl nanoparticles (BE-OPT) revealed 96.242percent (12 h) release. The release kinetic investigation with the optimised batch of Berberine HCl nanoparticles (BE-OPT) demonstrated that Higuchi's release kinetic model was followed. The chosen (optimised) nanoparticles were sealed in amber-coloured bottles with cotton plugs and caps. All were kept for six months at 40±2°C/75±5% RH and examined for their physical appearance and drug content at certain intervals.
Cite this article:
Vinod Kumar, Prashant Kumar, Saurabh Sharma. Application of Box-Behnken Experimental Design in Process Parameter Optimization for Production of Berberine HCl loaded Chitosan Coated Sodium Alginate Nanoparticles. Research Journal of Pharmacy and Technology 2023; 16(3):1139-6. doi: 10.52711/0974-360X.2023.00190
Vinod Kumar, Prashant Kumar, Saurabh Sharma. Application of Box-Behnken Experimental Design in Process Parameter Optimization for Production of Berberine HCl loaded Chitosan Coated Sodium Alginate Nanoparticles. Research Journal of Pharmacy and Technology 2023; 16(3):1139-6. doi: 10.52711/0974-360X.2023.00190 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-3-26
1. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 2014; 70: 512–516. doi:10.1016/j.jaad.2013.11.013
2. Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA - J Am Med Assoc 2020; 323: 1945–1960. doi:10.1001/jama.2020.4006
3. Armstrong AW. Psoriasis provoked or exacerbated by medications: Identifying culprit drugs. JAMA Dermatology 2014; 150: 963. doi:10.1001/jamadermatol.2014.1019
4. Padmini Iriventi, N. Vishal Gupta. Formulation and Evaluation of Herbal Cream for Treating Psoriasis. Research J. Pharm. and Tech. 2021; 14(1):167-170. doi: 10.5958/0974-360X.2021.00029.9
5. Rinku Y. Pati, Shubhangi A. Patil, Niranjan D. Chivate, Yogesh N. Patil. Herbal Drug Nanoparticles: Advancements in Herbal Treatment.Research J. Pharm. and Tech. 2018; 11(1): 421-426. doi: 10.5958/0974-360X.2018.00078.1
6. Ankur Choubey, Pawan Bajpai, Shelesh Jain. Nanomedicines based Drug delivery system and their significant role in Herbal Formulations: A Review. Research J. Pharm. and Tech. 2020; 13(10):5034-5039. doi: 10.5958/0974-360X.2020.00881.1
7. SHUSTER CAG & S. Lack of effect of topical indomethacin on psoriasis C. 1987; 381–384
8. Neag MA, Mocan A, Echeverría J, Pop RM, Bocsan CI, Cri¸ san G and Buzoianu AD (2018) Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front. Pharmacol. 9:557. doi: 10.3389/fphar.2018.00557
9. Deepshikha Verma, Pradeep Kumar Samal. Evaluation of Synergistic Analgesic Activity of Berberine and Asiatic Acid in Mice. Research J. Pharm. and Tech. 2020; 13(12):6081-6085. doi: 10.5958/0974-360X.2020.01060.4
10. Vadivelan Ramachandran, Ibrahim Khan, Sudeep Sugumar, Vikash Sundaram. Antioxidant, Anti-inflammatory and Anticholinergic action of berberine attenuates diabetic encephalopathy: Behavioral and Biochemical evidences. Research J. Pharm. and Tech. 2020; 13(10):4550-4556. doi: 10.5958/0974-360X.2020.00802.1
11. Meng, Z., Yu, Y., Zhang, Y., Yang, X., Lv, X., Guan, F., Hatch, G. M., Zhang, M., & Chen, L. Highly bioavailable Berberine formulation improves Glucocorticoid Receptor-mediated Insulin Resistance via reduction in association of the Glucocorticoid Receptor with phosphatidylinositol-3-kinase. International journal of biological sciences, (2020), 16(14), 2527–2541. https://doi.org/10.7150/ijbs.39508
12. Birgani, A.G., Abedi, P., Zare, K., & Assadpoor, S. (2013). The effect of berberine on patients with psoriasis. Arak Medical University Journal, 15, 61-67.
13. Pradhan M, Alexander A, Singh MR, et al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother 2018; 107: 447–463. doi:10.1016/j.biopha.2018.07.156
14. El-Shenawy AA, Ahmed MM, Mansour HF, et al. Torsemide Fast Dissolving Tablets: Development, Optimization Using Box–Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment. AAPS PharmSciTech 2017; 18: 2168–2179. doi:10.1208/s12249-016-0697-6
15. Motwani SK, Chopra S, Talegaonkar S, et al. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008; 68: 513–525. doi:10.1016/j.ejpb.2007.09.009
16. Jelvehgari M, Nokhodchi A, Rezapour M, et al. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Indian J Pharm Sci 2010; 72: 72–78. doi:10.4103/0250-474X.62251
17. Akhter MH, Ahmad A, Ali J, et al. Formulation and development of CoQ10-loaded s-SNEDDS for enhancement of oral bioavailability. J Pharm Innov 2014; 9: 121–131. doi:10.1007/s12247-014-9179-0
18. Bohrey S, Chourasiya V, Pandey A. Polymeric nanoparticles containing diazepam: Preparation, optimization, characterization, in-vitro drug release and release kinetic study. Nano Converg 2016; 3: 3–9. doi:10.1186/s40580-016-0061-2
19. Kohli K, Mujtaba A, Malik R, et al. Development of natural polysaccharide–based nanoparticles of berberine to enhance oral bioavailability: Formulation, optimization, ex vivo, and in vivo assessment. Polymers (Basel) 2021; 13: 1–14. doi:10.3390/polym13213833
20. Dwarampudi LP, Palaniswamy D, Nithyanantham M, et al. Antipsoriatic activity and cytotoxicity of ethanolic extract of Nigella sativa seeds. Pharmacogn Mag 2012; 8: 268–272. doi:10.4103/0973-1296.103650
21. Yetilmezsoy K, Demirel S, Vanderbei RJ. Response surface modeling of Pb(II) removal from aqueous solution by Pistacia vera L.: Box-Behnken experimental design. J Hazard Mater 2009; 171: 551–562. doi:10.1016/j.jhazmat.2009.06.035
22. Kaur N, Kaur M, Mahajan M, et al. Development, characterization and evaluation of nanocarrier based formulations of antipsoriatic drug “acitretin” for skin targeting. J Drug Deliv Sci Technol 2020; 60: 102010. doi:10.1016/j.jddst.2020.102010
23. Joshi HR, Kanaki N. Quantitative analysis of berberine in an ayurvedic formulation-Rasayana Churna by UV spectrophotometry. J Pharm Sci Biosci Res 2013; 3: 32–34.
24. Apeksha Saraf, Nidhi Dubey, Nitin Dubey, Mayank Sharma. Box Behnken Design Based Development of Curcumin Loaded Eudragit S100 Nanoparticles for Site-Specific Delivery in Colon Cancer. Research J. Pharm. and Tech 2019; 12(8):3672-3678. doi: 10.5958/0974-360X.2019.00627.9
25. Anjali Sharma, Kumar Guarve, Ranjit Singh. Application of Box–Behnken Design and Desirability function in the Optimization of Aceclofenac-Loaded Micropsonges for Topical Application. Research Journal of Pharmacy and Technology. 2021; 14(12):6295-3. doi: 10.52711/0974-360X.2021.01089
26. Pauluk D, Padilha AK, Khalil NM, et al. Chitosan-coated zein nanoparticles for oral delivery of resveratrol: Formation, characterization, stability, mucoadhesive properties and antioxidant activity. Food Hydrocoll 2019; 94: 411–417. doi:10.1016/j.foodhyd.2019.03.042
27. D.K. Sanghi, Rakesh Tiwle. Herbal Drugs an Emerging Tool for Novel Drug Delivery Systems. Research J. Pharm. and Tech. 6(9): September 2013; Page 962-966.
28. Jainey P. James, Sneh Priya, Divya Jyothi. Effect of PLGA polymer on Antimicrobial Activity and the Release Studies of Nanoparticle Hydrogel Containing Mimosa pudica Extract. Research J. Pharm. and Tech 2018; 11(7): 2876-2880. doi: 10.5958/0974-360X.2018.00530.9
29. Tefas, L. R., Tomuţă, I., Achim, M., & Vlase, L. (2015). Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul medical (1957), 88(2), 214–223. https://doi.org/10.15386/cjmed-418
30. Fadilah Fadilah, Vallas Aditiar Widodo, Rahardi Prasetia Priawan, Ericko Ongko Joyo, Hadin Abdurrohman, Fatmawaty, Rafika Indah Paramita1, Norma Nur Azizah. Synthesis Nanoparticle extract of Clove (Syzygium aromaticum L.) and Characterization by Differential Scanning Colorimetry Profiling and its Activities as Inhibitor of HeLa Cell lines. Research J. Pharm. and Tech. 2019; 12(7): 3355-3358. doi: 10.5958/0974-360X.2019.00566.3